Sarcoma de Ewing extraóseo
Bruballa, Rocío C; Boccalatte, Luis A; Abuawad, Carla Y; Jaén, Ana; Figari, Marcelo F.
Medicina (B.Aires)
; 79(3): 236-236, June 2019. ilus
Artículo en Español | LILACS | ID: biblio-1020068
Documentos relacionados
Immune checkpoint blockade provokes resident memory T cells to eliminate head and neck cancer.
Methodological Issues with Head and Neck Cancer Prognostic Risk Prediction Models.
Dual checkpoint T(h1)eamwork makes the anti-cancer dream work.
Factors associated with masticatory function as measured with the Mixing Ability Test in patients with head and neck cancer before and after treatment: a prospective cohort study.
Current radiotherapy for recurrent head and neck cancer in the modern era: a state-of-the-art review.
Head and neck cancer patient-derived tumouroid cultures: opportunities and challenges.
Nrf2 targeting in overcoming ferroptosis evasion in head and neck cancer.
Methylation of histone H3 lysine 36 is a barrier for therapeutic interventions of head and neck squamous cell carcinoma.
Proton therapy for pediatric head and neck malignancies.
Nanoparticle therapy for head and neck cancers.